BioCorRx Inc (BICX)
0.81
-0.09
(-10.00%)
USD |
OTCM |
May 17, 14:11
BioCorRx Revenue (Quarterly): 0.0189M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0189M |
| September 30, 2023 | 0.0101M |
| June 30, 2023 | 0.0196M |
| March 31, 2023 | 0.0404M |
| December 31, 2022 | 0.0829M |
| September 30, 2022 | 0.0944M |
| June 30, 2022 | 0.016M |
| March 31, 2022 | 0.0205M |
| December 31, 2021 | 0.0136M |
| September 30, 2021 | 0.0088M |
| June 30, 2021 | 0.0157M |
| March 31, 2021 | 0.0101M |
| December 31, 2020 | 0.0222M |
| September 30, 2020 | 0.0298M |
| June 30, 2020 | 0.0337M |
| March 31, 2020 | 0.0369M |
| December 31, 2019 | 0.0624M |
| September 30, 2019 | 0.0466M |
| June 30, 2019 | 0.066M |
| March 31, 2019 | 0.0653M |
| December 31, 2018 | 0.0517M |
| September 30, 2018 | 0.0786M |
| June 30, 2018 | 0.0987M |
| March 31, 2018 | 0.1477M |
| December 31, 2017 | 0.1649M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.1476M |
| June 30, 2017 | 0.2105M |
| March 31, 2017 | 0.1342M |
| December 31, 2016 | 0.1158M |
| September 30, 2016 | 0.1676M |
| June 30, 2016 | 0.1879M |
| March 31, 2016 | 0.2304M |
| December 31, 2015 | 0.0733M |
| September 30, 2015 | 0.1182M |
| June 30, 2015 | 0.4578M |
| March 31, 2015 | 0.2755M |
| December 31, 2014 | 0.368M |
| September 30, 2014 | 0.434M |
| June 30, 2014 | 0.238M |
| March 31, 2014 | 0.1308M |
| December 31, 2013 | -0.4496M |
| September 30, 2013 | 0.2774M |
| June 30, 2013 | 0.50M |
| March 31, 2013 | 0.3872M |
| December 31, 2012 | 0.3641M |
| September 30, 2012 | 0.064M |
| June 30, 2012 | 0.1792M |
| March 31, 2012 | 0.2609M |
| December 31, 2011 | 0.0936M |
| September 30, 2011 | 0.3443M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0088M
Minimum
Sep 2021
0.0944M
Maximum
Sep 2022
0.0342M
Average
0.0222M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
| Encompass Health Corp | 1.316B |
| Pediatrix Medical Group Inc | 495.10M |
| US Physical Therapy Inc | 155.68M |
| The Oncology Institute Inc | 94.67M |
| American Oncology Network Inc | 364.34M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.9685M |
| Total Expenses (Quarterly) | 0.6988M |
| EPS Diluted (Quarterly) | -0.11 |
| Enterprise Value | 8.646M |
| Gross Profit Margin (Quarterly) | 31.08% |
| Profit Margin (Quarterly) | -5.11K% |
| Earnings Yield | -55.56% |
| Normalized Earnings Yield | -54.29 |